PetCore Oncology

PetCure Oncology is a U.S.-based veterinary oncology company that operates a network of pet cancer treatment centers focused on advanced radiation oncology and medical oncology services for dogs and cats. The company was founded in 2014 to expand access to stereotactic radiation therapy, including stereotactic radiosurgery and stereotactic radiotherapy, for veterinary patients. PetCure partners with specialty veterinary hospitals and uses a distributed clinical network model supported by board-certified veterinary oncologists and radiation specialists. Its core commercial offering is comprehensive pet cancer care, with SRS/SRT as a signature treatment modality and additional medical oncology support at affiliated sites. The company appears to be an operating healthcare services business rather than a drug-development biotech.